Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ribociclib + Binimetinib in NRAS-Mutant Melanoma
NCT01781572Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jun 2013
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of ribociclib, binimetinib in melanoma, sponsored by Pfizer. Started Jun 2013; status: completed.
02
Drugs
ribociclibbinimetinib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01781572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01781572.